Claudio Festuccia

6.9k total citations
164 papers, 5.3k citations indexed

About

Claudio Festuccia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Claudio Festuccia has authored 164 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 59 papers in Pulmonary and Respiratory Medicine and 56 papers in Oncology. Recurrent topics in Claudio Festuccia's work include Prostate Cancer Treatment and Research (54 papers), Protease and Inhibitor Mechanisms (14 papers) and Peptidase Inhibition and Analysis (13 papers). Claudio Festuccia is often cited by papers focused on Prostate Cancer Treatment and Research (54 papers), Protease and Inhibitor Mechanisms (14 papers) and Peptidase Inhibition and Analysis (13 papers). Claudio Festuccia collaborates with scholars based in Italy, United States and Spain. Claudio Festuccia's co-authors include Giovanni Luca Gravina, Mauro Bologna, Paola Muzi, Adriano Angelucci, Francesco Marampon, Carlo Vicentini, Leda Biordi, Vincenza Dolo, Vincenzo Tombolini and Alessandro Colapietro and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer.

In The Last Decade

Claudio Festuccia

161 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudio Festuccia Italy	45	2.8k	1.6k	1.1k	1.1k	536	164	5.3k
Juliane M. Jürgensmeier United States	30	3.7k 1.3×	1.3k 0.8×	533 0.5×	738 0.7×	580 1.1×	69	5.4k
Gary A. Piazza United States	48	3.5k 1.2×	1.5k 0.9×	536 0.5×	1.1k 1.0×	562 1.0×	171	6.9k
Ulrich Pfeffer Italy	41	3.6k 1.3×	1.3k 0.8×	757 0.7×	1.2k 1.1×	860 1.6×	143	6.3k
F. Michael Yakes United States	15	3.4k 1.2×	2.3k 1.4×	1.1k 1.0×	679 0.6×	428 0.8×	20	5.9k
Markus Wartmann Switzerland	39	3.8k 1.3×	2.1k 1.3×	680 0.6×	650 0.6×	526 1.0×	89	6.9k
Alfredo Budillon Italy	50	3.7k 1.3×	2.6k 1.6×	974 0.9×	1.1k 1.0×	686 1.3×	203	6.7k
Damu Tang Canada	43	3.8k 1.4×	1.5k 0.9×	706 0.6×	1.3k 1.2×	766 1.4×	132	6.0k
Vivek M. Rangnekar United States	46	4.1k 1.4×	1.3k 0.8×	534 0.5×	960 0.9×	657 1.2×	119	6.0k
Ming Zhao United States	42	3.1k 1.1×	1.4k 0.9×	615 0.5×	567 0.5×	362 0.7×	133	5.3k

Countries citing papers authored by Claudio Festuccia

Since Specialization

Citations

This map shows the geographic impact of Claudio Festuccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Festuccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Festuccia more than expected).

Fields of papers citing papers by Claudio Festuccia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Festuccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Festuccia. The network helps show where Claudio Festuccia may publish in the future.

Co-authorship network of co-authors of Claudio Festuccia

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Festuccia. A scholar is included among the top collaborators of Claudio Festuccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Festuccia. Claudio Festuccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chonco, Louis, Veronica Zelli, Andrés J. García, et al.. (2024). General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma. Pharmaceutics. 16(5). 610–610.

Festuccia, Claudio, Riccardo Castelli, Alessio Lodola, et al.. (2023). A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence. Pharmaceuticals. 16(10). 1452–1452. 1 indexed citations

Gravina, Giovanni Luca, Alessandro Colapietro, A. Mancini, et al.. (2022). ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers. 14(2). 289–289. 21 indexed citations

Cassandri, Matteo, Silvia Pomella, Luisa Milazzo, et al.. (2021). MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells. International Journal of Molecular Sciences. 22(19). 10671–10671. 16 indexed citations

Colapietro, Alessandro, Giovanni Luca Gravina, Irene Fasciani, et al.. (2020). Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo. Journal of Oncology. 2020. 1–16. 10 indexed citations

Colapietro, Alessandro, A. Mancini, Flora Vitale, et al.. (2020). Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma. International Journal of Molecular Sciences. 21(2). 423–423. 39 indexed citations

Festuccia, Claudio, Andrea Mancini, Giovanni Luca Gravina, et al.. (2019). Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth. Cells. 9(1). 32–32. 23 indexed citations

Marampon, Francesco, Flavio Leoni, A. Mancini, et al.. (2018). Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. Journal of Cancer Research and Clinical Oncology. 145(2). 393–409. 29 indexed citations

Vignaroli, Gianluca, Claudio Zamperini, Anna Lucia Fallacara, et al.. (2017). Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model. Journal of Medicinal Chemistry. 60(14). 6305–6320. 31 indexed citations

10.

Marampon, Francesco, Francesca Megiorni, Simona Camero, et al.. (2017). HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells. Cancer Letters. 397. 1–11. 80 indexed citations

11.

Vignaroli, Gianluca, Claudio Zamperini, Claudio Festuccia, et al.. (2016). Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells. Molecular Cancer Therapeutics. 15(7). 1535–1544. 30 indexed citations

12.

Bruera, Gemma, Katia Cannita, Eleonora Palluzzi, et al.. (2014). Bioclinical Parameters Driving Decision-Making of Subsequent Lines of Treatment in Metastatic Castration-Resistant Prostate Cancer. BioMed Research International. 2014. 1–7. 10 indexed citations

13.

Marampon, Francesco, Giovanni Luca Gravina, Agnese Di Rocco, et al.. (2011). MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals. Molecular Cancer Therapeutics. 10(1). 159–168. 68 indexed citations

14.

Gravina, Giovanni Luca, Francesco Marampon, Leda Biordi, et al.. (2011). The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. Endocrine Related Cancer. 18(4). 385–400. 28 indexed citations

15.

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2010). Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. Molecular Cancer Therapeutics. 9(8). 2243–2254. 51 indexed citations

16.

Festuccia, Claudio, D. Dondi, Margherita Piccolella, et al.. (2010). Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. The Prostate. 70(12). 1340–1349. 20 indexed citations

17.

Gravina, Giovanni Luca, Claudio Festuccia, Danilo Millimaggi, et al.. (2009). Bicalutamide Demonstrates Biologic Effectiveness in Prostate Cancer Cell Lines and Tumor Primary Cultures Irrespective of Her2/neu Expression Levels. Urology. 74(2). 452–457. 5 indexed citations

18.

Festuccia, Claudio, Giovanni Luca Gravina, Paola Muzi, et al.. (2008). Her2 crosstalks with TrkA in a subset of prostate cancer cells: Rationale for a guided dual treatment. The Prostate. 69(4). 337–345. 11 indexed citations

19.

Gravina, Giovanni Luca, Claudio Festuccia, Giuseppe Paradiso Galatioto, et al.. (2007). Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer. Urology. 70(4). 728–733. 30 indexed citations

20.

Bianchini, Andrea, Isabelle Gloaguen, Leda Biordi, et al.. (2004). Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochemical Pharmacology. 69(3). 385–394. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact